04/19/2024
7:03 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024
7:15 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
7:20 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2024
7:10 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2024
7:06 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/23/2024
7:15 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:17 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
02/16/2024
7:25 PM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024
3:14 PM | YS Biopharma (Subject)
YS Biopharma Co., Ltd. (Subject)
Zhang /MD Yi (Filed by)
| Form SC 13G/A | |
02/14/2024
10:23 AM | Wong Fung Ching (Filed by)
YS Biopharma (Subject)
YS Biopharma Co., Ltd. (Subject)
| Form SC 13D | |
02/14/2024
6:59 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:01 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:05 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/09/2024
6:10 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024
11:15 PM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form EFFECT | |
01/26/2024
5:03 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/23/2024
3:18 PM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form POS AM | |
01/22/2024
4:10 PM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
6:10 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
11:43 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
5:37 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2023
7:45 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2023
7:46 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 424B3 | |
10/26/2023
7:45 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2023
8:10 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2023
8:13 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 424B3 | |
09/25/2023
5:12 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 424B3 | |
09/25/2023
5:07 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 424B3 | |
08/25/2023
7:00 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2023
7:00 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2023
7:00 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 424B3 | |
08/10/2023
11:15 PM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form EFFECT | |
06/05/2023
11:15 PM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form EFFECT | |
06/05/2023
3:03 PM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 424B3 | |
06/01/2023
8:00 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/18/2023
7:42 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2023
9:38 AM | YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
